Literature DB >> 11668491

Estimating the world cancer burden: Globocan 2000.

D M Parkin1, F Bray, J Ferlay, P Pisani.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11668491     DOI： 10.1002/ijc.1440

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  1007 in total

1.  Establishment of a human hepatoma multidrug resistant cell line in vitro.

Authors:  Yuan Zhou; Xian-Long Ling; Shi-Wei Li; Xin-Qiang Li; Bin Yan
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.

Authors:  Yuzo Umeda; Hiroaki Matsuda; Hiroshi Sadamori; Hiroyoshi Matsukawa; Takahito Yagi; Toshiyoshi Fujiwara
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

3.  Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.

Authors:  Celia Pamela Corona-Villalobos; Vivek Gowdra Halappa; Susanne Bonekamp; John Eng; Diane Reyes; David Cosgrove; Neda Rastegar; Li Pan; Timothy M Pawlik; Ihab R Kamel
Journal:  Invest Radiol       Date:  2015-04       Impact factor: 6.016

4.  Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies.

Authors:  Xiao-Feng He; Wu Wei; Jiao Su; Zi-Xuan Yang; Yi Liu; Ying Zhang; Da-Peng Ding; Wei Wang
Journal:  Mol Biol Rep       Date:  2011-12-10       Impact factor: 2.316

5.  Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma.

Authors:  Rong-Rong Wei; Mei-Yin Zhang; Hui-Lan Rao; Heng-Ying Pu; Hui-Zhong Zhang; Hui-Yun Wang
Journal:  Med Oncol       Date:  2011-12-07       Impact factor: 3.064

6.  Influence of peroxisome proliferator-activated receptor (PPAR)gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Masakatsu Nakamura; Fangyu Wang; Naoko Maruyama; Yoshio Kamiya; Masahiko Nakamura; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata; Hiroshi Nakano
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

7.  Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver.

Authors:  N Obeng-Adjei; D K Choo; J Saini; J Yan; P Pankhong; A Parikh; J S Chu; D B Weiner
Journal:  Cancer Gene Ther       Date:  2012-10-05       Impact factor: 5.987

8.  Effects of copaene, a tricyclic sesquiterpene, on human lymphocytes cells in vitro.

Authors:  Hasan Türkez; Kübra Celik; Başak Toğar
Journal:  Cytotechnology       Date:  2013-11-28       Impact factor: 2.058

9.  Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.

Authors:  Dong Ho Lee; Jeong Min Lee; Mi Hye Yu; Bo Yun Hur; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh; Jung-Hwan Yoon; Yoon Jun Kim; Jeong-Hoon Lee; Su Jong Yu; Joon Koo Han
Journal:  Eur Radiol       Date:  2019-01-14       Impact factor: 5.315

Review 10.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.